Intersect ENT Expands Footprint to 55 KSF at Menlo Park HQ

Intersect ENT has recently completed the leasing agreement for an expansion at its 1555 Adams Drive home in Menlo Park, CA. The company that deals with improving quality of life for patients with ear, nose and throat conditions inked the deal with landlord Tarlton Properties, Inc. The expansion means that

By Alex Girda, Associate Editor

Intersect ENT has completed a deal for an 18,000-square-foot expansion at its 1555 Adams Drive headquarters in Menlo Park The life sciences company, which is the property’s sole tenant , inked the deal with owner Tarlton Properties, Inc.

The deal increases Intersect ENT’s footprint at 1555 Adans to 50,000 square feet.Intersect ENT’s CEO, Lisa Earnhardt, explained that the building’s size, amenities, location and setting are a good match for the company’s research and development activities.

Intersect ENT focuses on creating therapies for patients with ear, nose, and throat conditions. Currently, The company’s main focus is chronic sinusitis, a common and often debilitating condition. Intersect ENT holds 25 patents in the United States and more than 85 patents and pending applications worldwide.

For more San Francisco area market data, click here.